Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Carcinogen Worry Causes Generic Zantac Recall at U.S. Pharmacies

Sept. 26, 2019, 5:58 PM

Some generic Zantac is being pulled from major chain pharmacies in the U.S. shortly after French officials recalled all versions of the popular stomach drug amid a global investigation into a carcinogen found in the pills.

Canadian drugmaker Apotex Inc. is recalling its over-the-counter generic Zantac tablets made for Walgreens Boots Alliance Inc., Walmart Inc. and Rite Aid Corp., the U.S. Food and Drug Administration said in a statement Sept. 26. France’s drug safety regulator, the Agence Nationale de Sécurité du Médicament, said in a statement dated Sept. 25 that it ordered a recall of all brand-name and ...